# POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

> **NCT07220720** · PHASE2 · RECRUITING · sponsor: **University of Florida** · enrollment: 30 (estimated)

## Conditions studied

- Prostate

## Interventions

- **DRUG:** Flotufolastat F 18

## Key facts

- **NCT ID:** NCT07220720
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2030-07-15
- **Final completion:** 2032-11-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07220720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07220720, "POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07220720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*